Cover Image
市場調查報告書

腦性麻痺:全球臨床實驗趨勢

Cerebral Palsy Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 222289
出版日期 內容資訊 英文 113 Pages
訂單完成後即時交付
價格
Back to Top
腦性麻痺:全球臨床實驗趨勢 Cerebral Palsy Global Clinical Trials Review, H1, 2017
出版日期: 2017年05月31日 內容資訊: 英文 113 Pages
簡介

本報告提供腦性麻痺治療藥相關之臨床實驗最新趨勢分析,提供您G7 (主要7國) 及E7 (新興7國) 各國的臨床實驗數量,並彙整受驗人數,有潛力的贊助商,參與臨床實驗的主要企業和機關,有潛力的藥劑等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦性麻痺的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統疾病治療藥臨床實驗上腦性麻痺的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

腦性麻痺治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4259CTIDB

GlobalData's clinical trial report, "Cerebral Palsy Global Clinical Trials Review, H1, 2017" provides an overview of Cerebral Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Palsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Cerebral Palsy to Central Nervous System Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Cerebral Palsy Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 111

  • Abbreviations 111
  • Definitions 111
  • Research Methodology 112
  • Secondary Research 112
  • About GlobalData 113
  • Contact Us 113
  • Source 113

List of Tables

List of Tables

  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
  • Cerebral Palsy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 17
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 112
Back to Top